SITC strategic vision: prevention, premalignant immunity, host and environmental factors

SITC strategic vision: prevention, premalignant immunity, host and environmental factors

Cancer immunotherapy has improved the survival of a subset of patients by harnessing the power of the immune system to find and destroy malignant cells. The immune system also protects the host by destroying developing premalignant and malignant tumors. Advancing our knowledge of premalignant immuni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Raymond H Kim, Christian M Capitini, Mary L Disis, Claire Vanpouille-Box, Laszlo Radvanyi, Jennifer Wargo, Sasha E Stanton, Jennifer McQuade, Saman Maleki Vareki, Tullia C Bruno, Kristin G Anderson, Adnan Rajeh, Lauren K Hughes, Kelly J Baines, Megan M Y Hong, Phillip Awadalla
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/3/e010419.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
by: Francesco M Marincola, et al.
Published: (2025-01-01)

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
by: Deborah Collyar, et al.
Published: (2025-03-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Popular writing in America : the interaction of style and audience /
by: McQuade, Donald
Published: (1974)

Mutation Profiling of Premalignant Colorectal Neoplasia
by: Jakub Karczmarski, et al.
Published: (2019-01-01)

Management approach to patients with premalignant lesions of the stomach
by: V. V. Tsukanov, et al.
Published: (2013-07-01)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-06-01)

Characteristics of the gut virome in patients with premalignant colorectal adenoma
by: Pan Zhang, et al.
Published: (2025-05-01)

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
by: John Barrett, et al.
Published: (2020-10-01)

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy
by: Pedro J Romero, et al.
Published: (2025-03-01)

PREDICTION OF UNIT VALUE INDEX OF EXPORTS OF SITC 897 JEWELRY AND PRECIOUS GOODS GROUP IN INDONESIA
by: Grace Lucyana Koesnadi, et al.
Published: (2024-10-01)

SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development
by: James L Gulley, et al.
Published: (2025-06-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
by: Raffit Hassan, et al.
Published: (2022-05-01)

Comparison of Chromoendoscopy and Conventional Endoscopy in the Detection of Premalignant Gastric Lesions
by: Seyed Alireza Taghavi, et al.
Published: (2009-01-01)

Oncogene-Induced Senescence Transcriptomes Signify Premalignant Colorectal Adenomas
by: Sofian Al Shboul, et al.
Published: (2025-03-01)

The use of Velscope to assess cellular changes occuring in oral premalignancy
by: Sonal Shah, et al.
Published: (2020-04-01)

Dental practitioner’s knowledge, opinions and methods of management of oral premalignancy and malignancy
by: Mohamed Abdullah Jaber
Published: (2011-01-01)

Office-based endoscopic surgery for benign, premalignant, and malignant laryngeal lesions
by: Petru Gurău, et al.
Published: (2025-07-01)

Endoscopic autofluorescence imaging in the diagnosis of premalignant lesions and laryngeal/hypopharyngeal cancer
by: I. О. Taraskina, et al.
Published: (2023-11-01)

Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
by: Vlad Denis Constantin, et al.
Published: (2023-10-01)

Bcl-2 expression and image analysis of premalignant and malignant colonic lesions
by: Sonia L. El-Sharkawy, et al.
Published: (2024-01-01)

Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
by: Charlie Garnett-Benson, et al.
Published: (2024-07-01)

SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy
by: Evan J Lipson, et al.
Published: (2025-06-01)

PREMALIGNANT LESIONS AND SYNCHRONOUS GASTRIC CANCER IN PATIENTS WITH LUNG AND HEAD AND NECK CANCER
by: О. V. Cheremisina, et al.
Published: (2016-02-01)

Overview of thermal ablation and LLETZ in cervical premalignant lesions: a narrative review
by: Sumedha Gupta, et al.
Published: (2024-12-01)

Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
by: Mario Sznol, et al.
Published: (2020-05-01)

Addendum 1: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Published: (2025-03-01)

Correction: SITC clinical Immuno-Oncology network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials
Published: (2024-03-01)

Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
by: Zornitsa Gorcheva
Published: (2022-11-01)

The Association of Streptococcus gallolyticus Subspecies pasteurianus Bacteremia with the Detection of Premalignant and Malignant Colonic Lesions
by: Gaurav Chand, et al.
Published: (2016-01-01)

Pharmaceutical and experimental-clinical aspects of photodynamic therapy combined with chemotherapy for malignant and premalignant tumors
by: Yu. S. Romanko, et al.
Published: (2025-03-01)

Prevalence and endoscopic-histological correlation of premalignant gastric lesions at a university hospital in Uruguay
by: Ignacio Moratorio, et al.
Published: (2025-01-01)

HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions
by: Rancés Blanco, et al.
Published: (2024-10-01)

Highly adaptive Lasso for estimation of heterogeneous treatment effects and treatment recommendation
by: Nizam Sohail, et al.
Published: (2025-08-01)

Premalignant and Malignant Skin Lesions in Two Recipients of Vascularized Composite Tissue Allografts (Face, Hands)
by: Jean Kanitakis, et al.
Published: (2015-01-01)

Virulence Genes of Helicobacter pylori Increase the Risk of Premalignant Gastric Lesions in a Colombian Population
by: Yeison Carlosama-Rosero, et al.
Published: (2022-01-01)

Comparative Study of Cervical Pap Smear and Visual Inspection of The Cervix To Detect Premalignant Disease of The Cervix
by: Rozhan Yassin Khalil, et al.
Published: (2020-06-01)

Experimental and clinical combined photodynamic therapy for malignant and premalignant lesions using various types of radiation
by: Y. S. Romanko, et al.
Published: (2024-09-01)

Human Papilloma Virus Expression in Iraqi Patients with Premalignant and Malignant Laryngeal Lesions: Immunohistochemical Study
by: Mais Mohammed Salim, et al.
Published: (2019-12-01)

Characterization of premalignant oral lesions diagnosed in a Stomatology service from Pinar del Río
by: Yamirka Aleida González Gómez, et al.
Published: (2024-01-01)